Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Trends and Outcomes of Hematopoietic Stem Cell Transplantation for Malignant Lymphoma in Japan between 2006 and 2021

Blood (2024) 144 (Supplement 1): 4472.

https://doi.org/10.1182/blood-2024-206515

Published: 2024

Journal Articles

Haploidentical Transplantation with Post-Transplant Cyclophosphamide Versus Single Cord Blood Transplantation for Adults with Relapsed/Refractory Malignant Lymphoma

Masashi Nishikubo, Yoshimitsu Shimomura, Yosuke Nakaya, Akihito Shinohara, Naoyuki Uchida, Nobuyuki Takayama, Hikaru Kobayashi, Yasufumi Uehara, Jun Ishikawa, Kazuya Ishiwata, Nobuhiro Hiramoto, Hideyuki Nakazawa, Fumihiko Ishimaru, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Eisei Kondo, Shinichi Kako

Blood (2023) 142 (Supplement 1): 3607.

https://doi.org/10.1182/blood-2023-178951

Published: 2023

Journal Articles

The Comparison between BM and PBSC for the Patients with Pre-Transplant Pulmonary Dysfunction in HLA-Matched Allo-HCT: Subgroup Analysis Exploring the Impact Based on HCT Factors

Blood (2023) 142 (Supplement 1): 3609.

https://doi.org/10.1182/blood-2023-174431

Published: 2023

Journal Articles

An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma

Blood (2023) 141 (10): 1159–1168.

https://doi.org/10.1182/blood.2022016862

Published: 2023

Includes: Supplemental data

Journal Articles

Reduced-Intensity Conditioning with Fludarabine/Busulfan Versus Fludarabine/Low-Dose Melphalan in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Kimimori Kamijo, Yoshimitsu Shimomura, Sung-Won Kim, Takahide Ara, Jun Ishikawa, Tetsuya Eto, Nobuhiro Hiramoto, Ishikazu Mizuno, Shigeru Kusumoto, Yasunori Ueda, Ken-ichi Matsuoka, Makoto Onizuka, Takahiro Fukuda, Yoshiko Atsuta, Eisei Kondo

Blood (2022) 140 (Supplement 1): 2393–2394.

https://doi.org/10.1182/blood-2022-159411

Published: 2022

Journal Articles

Pivotal Phase 2 Study of the EZH1 and EZH2 Inhibitor Valemetostat Tosylate (DS-3201b) in Patients with Relapsed or Refractory Adult T-Cell Leukemia/Lymphoma

Blood (2021) 138 (Supplement 1): 303.

https://doi.org/10.1182/blood-2021-146657

Published: 2021

Journal Articles

End-of-Treatment 18[F]-FDG PET Can Predict Progression-Free Survival in Patients Undergoing Bendamustine + Rituximab for First Relapsed/Recurrent Follicular Lymphoma: The Result of W- J H S NHL01 Study

Shinya Rai, MD PhD, Koji Kato, MD PhD, Junji Suzumiya, MD PhD, Koji Izutsu, MD PhD, Momoko Nishikori, MD PhD, Hirohiko Shibayama, MD PhD, Yoshinobu Maeda, MD PhD, Kenichi Yoshimura, PhD, Ukihide Tateishi, MD PhD, Toshihiro Miyamoto, MD PhD, Jun Ishikawa, MD PhD, Tsutomu Takahashi, MD PhD, Takahiro Yamauchi, MD PhD, Koichi Akashi, MD PhD, Yuzuru Kanakura, MD PhD

Blood (2019) 134 (Supplement_1): 5245.

https://doi.org/10.1182/blood-2019-126455

Published: 2019

Journal Articles

Elevated Serum Soluble Interleukin-2 Receptor Level Is a Useful Prognostic Factor for Disease-Specific Overall Survival in Patients with Newly Diagnosed Follicular Lymphoma before Initiation of Treatment

Blood (2019) 134 (Supplement_1): 3985.

https://doi.org/10.1182/blood-2019-126399

Published: 2019

Journal Articles

Efficacy of Yttrium-90 Iburitumomab Tiuxetan for Early Relapsed/Refractory Indolent B-Cell Lymphoma: A Single Institute Retrospective Analysis in the Rituximab Era

Keiichi Nakata, MD, Shigeo Fuji, MD PhD, Ryo Nakata, MD, Kazuhito Tsutsumi, MD, Shuhei Kida, MD, Midori Koike, MD, Yuma Tada, MD, Hiroaki Masaie, MD, Hitoshi Yoshida, MD, Jun Ishikawa, MD PhD

Blood (2018) 132 (Supplement 1): 5333.

https://doi.org/10.1182/blood-2018-99-112782

Published: 2018

Journal Articles

Safety and Efficacy of a Switch to Nilotinib in Patients with CML-CP Showing MMR to Imatinib: Results of a Multicenter Phase II Trial (NILSw Trial)

Hirohiko Shibayama, MD PhD, Tatsuya Kawaguchi, MD PhD, Junya Kuroda, MD PhD, Hirohisa Nakamae, MD PhD, Itaru Matsumura, MD PhD, Toshihiro Miyamoto, MD PhD, Jun Ishikawa, MD PhD, Tomohiko Kamimura, MD PhD, Kentaro Fukushima, MD PhD, Yutaka Imamura, MD PhD, Tetsuya Eto, MD PhD, Kazutaka Sunami, MD PhD, Mototsugu Shimokawa, PhD, Koichi Akashi, MD PhD, Yuzuru Kanakura, MD PhD

Blood (2016) 128 (22): 1914.

https://doi.org/10.1182/blood.V128.22.1914.1914

Published: 2016

Journal Articles

Discontinuation of Nilotinib in Patients with Chronic Myeloid Leukemia Who Have Maintained Deep Molecular Responses for at Least 2 Years: A Multicenter Phase 2 Stop Nilotinib (Nilst) Trial

Norimitsu Kadowaki, MD PhD, Tatsuya Kawaguchi, MD PhD, Junya Kuroda, MD PhD, Hirohisa Nakamae, MD PhD, Itaru Matsumura, MD PhD, Toshihiro Miyamoto, MD PhD, Jun Ishikawa, MD PhD, Koji Nagafuji, MD PhD, Yutaka Imamura, MD PhD, Hirohito Yamazaki, Mototsugu Shimokawa, PhD, Koichi Akashi, MD PhD, Yuzuru Kanakura, MD PhD

Blood (2016) 128 (22): 790.

https://doi.org/10.1182/blood.V128.22.790.790

Published: 2016

Journal Articles

Comparison of Outcomes after Double or Single-Unit Cord Blood Transplantation in Patients with Hematological Malignancies Using TBI-Containing Myeloablative Conditioning Regimen, a Retrospective Matched Control Study on Behalf of C-SHOT0507 and JSHCT Registry Data in Japan

Atsushi Wake, MD PhD, Shunro Kai, MD PhD, Masaya Okada, MD PhD, Koji Kato, MD, Naoyuki Uchida, MD PhD, Naoki Kobayashi, MDPhD, Nobuyuki Aotsuka, MD PhD, Jun Ishikawa, MD, Satoshi Takahashi, MD PhD, Tetsuya Eto, MD PhD, Shuichi Taniguchi, MD PhD, Yoshiko Atsuta, MDPhD, Shunichi Kato, MD PhD

Blood (2014) 124 (21): 2548.

https://doi.org/10.1182/blood.V124.21.2548.2548

Published: 2014

Journal Articles

Double-Unit Cord Blood Transplantation for Hematological Malignancies in Japan: Multicenter Phase II Study (C-SHOT 0507)

Atsushi Wake, MD, PhD, Shunro Kai, MD. PhD, Masaya Okada, MD, PhD, Mio Kurata, Yoshiko Atsuta, MD, Jun Ishikawa, MD, Masayuki Hino, M.D., Ph.D., Nobuyuki Aotsuka, MD, PhD, Masaharu Kasai, MD, PhD, Mahito Misawa, MD, PhD, Shuichi Taniguchi, MD, PhD, Shunichi Kato, MD, PhD

Blood (2011) 118 (21): 3071.

https://doi.org/10.1182/blood.V118.21.3071.3071

Published: 2011

Journal Articles

Prospective Isolation and Functional Characterization of Human Bone Marrow-Derived Hematopoietic Stem Cell-Supportive Mesenchymal Stromal Cells.

Yoshikazu Matsuoka, PhD, Yutaka Sasaki, MD, PhD, Masaya Takahashi, MD, Ryusuke Nakatsuka, PhD, Yasushi Uemura, MD, PhD, Masami Inoue, MD, Hiroyasu Ogawa, MD, PhD, Takayuki Takahashi, MD, PhD, Jun Ishikawa, MD, Masayuki Hino, MD, PhD, Yoshiaki Sonoda, MD, PhD

Blood (2010) 116 (21): 3852.

https://doi.org/10.1182/blood.V116.21.3852.3852

Published: 2010

Journal Articles

The Function of AML1 (RUNX1) C-Deletion Mutant in Hematopoietic Stem/Progenitor Cells.

Yusuke Satoh, Itaru Matsumura, Sachiko Ezoe, Hirokazu Tanaka, Takafumi Yokota, Jun Ishikawa, Kenji Oritani, Yuzuru Kanakura

Blood (2005) 106 (11): 1738.

https://doi.org/10.1182/blood.V106.11.1738.1738

Published: 2005

Journal Articles

Retrospective Analysis of 23 Cases with Human Herpesvirus-6 Associated Encephalitis after Allogeneic Hematopoietic Cell Transplantation.

Blood (2004) 104 (11): 5067.

https://doi.org/10.1182/blood.V104.11.5067.5067

Published: 2004

Journal Articles

Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages

Takafumi Yokota, Kenji Oritani, Isao Takahashi, Jun Ishikawa, Akifumi Matsuyama, Noriyuki Ouchi, Shinji Kihara, Tohru Funahashi, Andrea J. Tenner, Yoshiaki Tomiyama, Yuji Matsuzawa

Blood (2000) 96 (5): 1723–1732.

https://doi.org/10.1182/blood.V96.5.1723

Published: 2000

Journal Articles

Integrin-associated protein/CD47 regulates motile activity in human B-cell lines through CDC42

Hitoshi Yoshida, Yoshiaki Tomiyama, Jun Ishikawa, Kenji Oritani, Itaru Matsumura, Masamichi Shiraga, Takafumi Yokota, Yu Okajima, Megumu Ogawa, Jun-ichiro Miyagawa, Tetsuo Nishiura, Yuji Matsuzawa

Blood (2000) 96 (1): 234–241.

https://doi.org/10.1182/blood.V96.1.234

Published: 2000

Journal Articles

Stromal Cell CD9 Regulates Differentiation of Hematopoietic Stem/Progenitor Cells

Keisuke Aoyama, Kenji Oritani, Takafumi Yokota, Jun Ishikawa, Tetsuo Nishiura, Kensuke Miyake, Yuzuru Kanakura, Yoshiaki Tomiyama, Paul W. Kincade, Yuji Matsuzawa

Blood (1999) 93 (8): 2586–2594.

https://doi.org/10.1182/blood.V93.8.2586

Published: 1999

Journal Articles

Growth-Supporting Activities of Fibronectin on Hematopoietic Stem/Progenitor Cells In Vitro and In Vivo: Structural Requirement for Fibronectin Activities of CS1 and Cell-Binding Domains

Takafumi Yokota, Kenji Oritani, Hideki Mitsui, Keisuke Aoyama, Jun Ishikawa, Hiroyuki Sugahara, Itaru Matsumura, Schickwann Tsai, Yoshiaki Tomiyama, Yuzuru Kanakura, Yuji Matsuzawa

Blood (1998) 91 (9): 3263–3272.

https://doi.org/10.1182/blood.V91.9.3263

Published: 1998

NARROW

Trends and Outcomes of Hematopoietic Stem Cell Transplantation for Malignant Lymphoma in Japan between 2006 and 2021

Haploidentical Transplantation with Post-Transplant Cyclophosphamide Versus Single Cord Blood Transplantation for Adults with Relapsed/Refractory Malignant Lymphoma

The Comparison between BM and PBSC for the Patients with Pre-Transplant Pulmonary Dysfunction in HLA-Matched Allo-HCT: Subgroup Analysis Exploring the Impact Based on HCT Factors

An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma

Reduced-Intensity Conditioning with Fludarabine/Busulfan Versus Fludarabine/Low-Dose Melphalan in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Pivotal Phase 2 Study of the EZH1 and EZH2 Inhibitor Valemetostat Tosylate (DS-3201b) in Patients with Relapsed or Refractory Adult T-Cell Leukemia/Lymphoma

End-of-Treatment 18[F]-FDG PET Can Predict Progression-Free Survival in Patients Undergoing Bendamustine + Rituximab for First Relapsed/Recurrent Follicular Lymphoma: The Result of W- J H S NHL01 Study

Elevated Serum Soluble Interleukin-2 Receptor Level Is a Useful Prognostic Factor for Disease-Specific Overall Survival in Patients with Newly Diagnosed Follicular Lymphoma before Initiation of Treatment

Efficacy of Yttrium-90 Iburitumomab Tiuxetan for Early Relapsed/Refractory Indolent B-Cell Lymphoma: A Single Institute Retrospective Analysis in the Rituximab Era

Safety and Efficacy of a Switch to Nilotinib in Patients with CML-CP Showing MMR to Imatinib: Results of a Multicenter Phase II Trial (NILSw Trial)

Discontinuation of Nilotinib in Patients with Chronic Myeloid Leukemia Who Have Maintained Deep Molecular Responses for at Least 2 Years: A Multicenter Phase 2 Stop Nilotinib (Nilst) Trial

Comparison of Outcomes after Double or Single-Unit Cord Blood Transplantation in Patients with Hematological Malignancies Using TBI-Containing Myeloablative Conditioning Regimen, a Retrospective Matched Control Study on Behalf of C-SHOT0507 and JSHCT Registry Data in Japan

Double-Unit Cord Blood Transplantation for Hematological Malignancies in Japan: Multicenter Phase II Study (C-SHOT 0507)

Prospective Isolation and Functional Characterization of Human Bone Marrow-Derived Hematopoietic Stem Cell-Supportive Mesenchymal Stromal Cells.

The Function of AML1 (RUNX1) C-Deletion Mutant in Hematopoietic Stem/Progenitor Cells.

Retrospective Analysis of 23 Cases with Human Herpesvirus-6 Associated Encephalitis after Allogeneic Hematopoietic Cell Transplantation.

Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages

Integrin-associated protein/CD47 regulates motile activity in human B-cell lines through CDC42

Stromal Cell CD9 Regulates Differentiation of Hematopoietic Stem/Progenitor Cells

Growth-Supporting Activities of Fibronectin on Hematopoietic Stem/Progenitor Cells In Vitro and In Vivo: Structural Requirement for Fibronectin Activities of CS1 and Cell-Binding Domains

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only